Soluble-type hepatobiliary contrast agents for MR imaging
- PMID: 8428085
- DOI: 10.1002/jmri.1880030130
Soluble-type hepatobiliary contrast agents for MR imaging
Similar articles
-
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.Eur Radiol. 2004 Apr;14(4):559-78. doi: 10.1007/s00330-004-2236-1. Epub 2004 Feb 25. Eur Radiol. 2004. PMID: 14986050 Review.
-
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].Bildgebung. 1992 Dec;59(4):195-9. Bildgebung. 1992. PMID: 1292771 Clinical Trial. German.
-
[Magnetic resonance imaging of the liver: what kind of contrast agents?].Radiol Med. 2001 Sep;102(3):109-21. Radiol Med. 2001. PMID: 11677451 Review. Italian.
-
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.Radiographics. 2009 Oct;29(6):1725-48. doi: 10.1148/rg.296095515. Radiographics. 2009. PMID: 19959518
-
Mechanisms of action of liver contrast agents: impact for clinical use.J Comput Assist Tomogr. 1999 Nov;23 Suppl 1:S45-52. doi: 10.1097/00004728-199911001-00007. J Comput Assist Tomogr. 1999. PMID: 10608397 Review.
Cited by
-
[Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].Radiologe. 2004 Dec;44(12):1185-91. doi: 10.1007/s00117-004-1134-5. Radiologe. 2004. PMID: 15549226 Review. German.
-
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.Eur Radiol. 2004 Apr;14(4):559-78. doi: 10.1007/s00330-004-2236-1. Epub 2004 Feb 25. Eur Radiol. 2004. PMID: 14986050 Review.
-
Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.Radiat Oncol. 2010 May 27;5:44. doi: 10.1186/1748-717X-5-44. Radiat Oncol. 2010. PMID: 20507615 Free PMC article.
-
Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial.Korean J Radiol. 2001 Oct-Dec;2(4):210-5. doi: 10.3348/kjr.2001.2.4.210. Korean J Radiol. 2001. PMID: 11754328 Free PMC article. Clinical Trial.
-
[Contrast agents in MRT. Substance, effects, pharmacology and validity].Radiologe. 2004 Mar;44(3):273-83. doi: 10.1007/s00117-004-1026-8. Radiologe. 2004. PMID: 15287365 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical